BIOLASE To Present At The H.C. Wainwright's BIOCONNECT 2021 Investor Conference

Rhea-AI Summary

BIOLASE, Inc. (NASDAQ: BIOL) announced that Todd Norbe and John Beaver will provide an overview of the company at the H.C. Wainwright BIOCONNECT 2021 Investor Conference from January 11-14, 2021. A recorded presentation will be available on-demand starting January 11 at 6:00 a.m. ET on BIOLASE's website. Investors can also arrange virtual one-on-one meetings during the event. BIOLASE is a leader in dental lasers, with over 41,200 systems sold globally, offering innovative laser solutions for various dental procedures.

FOOTHILL RANCH, Calif., Jan. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements, at the H.C. Wainwright BIOCONNECT 2021 Investor Conference, which takes place January 11-14, 2021. A webcast of BIOLASE's recorded company presentation will be available on-demand beginning at 6:00 a.m. ET on January 11^th, and can be accessed in the investor relations section of BIOLASE's website at www.biolase.com.

Management will also be available for virtual one-on-one meetings with investors during the event. To request a meeting please contact your H.C. Wainwright representative or BIOLASE's investor relations firm at tkehrli@evcgroup.com. 

About BIOLASE, Inc.

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine.  BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals.  BIOLASE's proprietary laser products incorporate approximately 261 patented and 52 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times.  BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients.  BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications.  BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world.  Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-to-present-at-the-hc-wainwrights-bioconnect-2021-investor-conference-301200830.html

SOURCE BIOLASE, Inc.

FAQ

What is BIOLASE presenting at the H.C. Wainwright BIOCONNECT 2021 Investor Conference?

BIOLASE will provide an overview of the company and its recent achievements during the conference from January 11-14, 2021.

When will BIOLASE's presentation be available online?

BIOLASE's recorded presentation will be available on-demand starting January 11, 2021, at 6:00 a.m. ET.

How can investors meet with BIOLASE management during the conference?

Investors can request virtual one-on-one meetings with BIOLASE management by contacting their H.C. Wainwright representative or BIOLASE's investor relations firm.

What is the stock symbol for BIOLASE?

The stock symbol for BIOLASE is BIOL.

What types of products does BIOLASE offer?

BIOLASE develops and sells laser systems for dentistry, focusing on innovative technologies that improve patient care.